EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISIONAcceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader Creation of a global leading provider of kits for genomic typing and transplantation diagnostics Acquisition of a 100% proprietary products portfolio Deeper capabilities and larger scale with technological and commercial complementaritiesParis, July 1st, 2026 ,8 AM CET Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, today announces that it has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitutes the Lab Products division of CareDx, Inc., a US global precision...

DEKUPLE Group continues its European growth with a majority stake acquisition in subko&co in Poland Paris, July 1st, 2026 (8:00 a.m.) – DEKUPLE Group, a European leader in communication and data marketing, announces the acquisition of a majority stake in subko&co, a Polish agency combining performance marketing, programmatic campaigns, data analytics and content creation for digital campaigns and MarTech solutions). Founded in 2013 by Marta Subko, a graduate of Sciences Po Paris, subko&co supports companies in their digital transformation and communication strategies. The agency has notably distinguished itself through its ability to build bridges between the Polish and French-speaking markets, serving both local and international clients. Based in Warsaw, subko&co has developed recognized expertise in delivering digital...

Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody Totality of evidence from the Phase II SAFE KIDNEY II trial supports initiation of pivotal Phase II/III trial later this year Ipsen expands rare disease portfolio to include serious and frequent post-transplant infection with no targeted approved treatmentsPARIS, FRANCE AND SCHLIEREN/ZURICH, SWITZERLAND, 01 JULY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The anticipated acquisition is focused on potravitug, which is a Phase II clinical-stage antibody against the BK polyomavirus (BKPyV). BK polyomavirus associated nephropathy...

SAN DIEGO and TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced the closing of the plan of arrangement (announced on November 19, 2025 and February 24, 2026) pursuant to which HS North America Ltd. (the “Purchaser”), a wholly owned subsidiary of Hanmi Pharmaceutical Co. Ltd. (“Hanmi”, and together with the Purchaser, the “Hanmi Purchasers”) acquired all of the issued and outstanding common shares of Aptose (the “Common Shares”) that were not currently owned or controlled by the Hanmi Purchasers or their respective affiliates (the “Arrangement”). Under the terms of the...

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCID: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) announces that UpEnergy Group failed to pay the closing payment of US$4.9 million (the “Buyout Payment Default”) under the previously announced Community Carbon Buyout Agreement between UpEnergy Group, Community Carbon (collectively, the “UPE Parties”) and the Company dated March 12, 2026 (the “Buyout Agreement“). As a result of the Buyout Payment Default, the Buyout Agreement terminated in accordance with its terms, and the Community Carbon Stream remains in full force and effect. Pursuant to the terms of the Buyout Agreement, the UPE Parties agreed to acquire the Company’s interest in the Community Carbon Stream and related carbon credit inventory for total consideration...

HARTFORD, Conn. and BOSTON, June 30, 2026 (GLOBE NEWSWIRE) — Eversource Energy (NYSE:ES) (“Eversource”) today announced that it has successfully completed the sale of Aquarion Water Company (“AWC”), consistent with all regulatory terms and requirements, to Aquarion Water Authority (“AWA”), a quasi-public corporation and political subdivision of the State of Connecticut and a standalone water authority alongside the South Central Connecticut Regional Water Authority (“RWA”). The total transaction purchase price was $2.4 billion cash. The adjusted net equity proceeds of approximately $1.7 billion will be used to displace Eversource debt, delivering on our commitment to strengthen the Eversource balance sheet. On January 27, 2025, Eversource entered a definitive agreement to sell AWC to AWA. The sale was approved by the Connecticut...

HAMPTON, N.H., June 30, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE:UTL) (“Unitil” or the “Company”) (unitil.com) today announced that it completed the purchase of Aquarion Water Company of New Hampshire, Inc. and Abenaki Water Co., Inc. (the “Aquarion Companies”) from the Aquarion Water Authority (“AWA”). The Stock Purchase Agreement (the “Agreement”) between Unitil and the AWA was first announced on May 6, 2025 and subsequently amended, including to limit Unitil’s purchase to the two Aquarion Companies. All conditions of the Agreement, as amended, including the receipt of approvals from the New Hampshire and Maine Public Utilities Commissions, were materially completed as of the closing date. The water systems of the Aquarion Companies include approximately 150 miles of water distribution mains and serve approximately 11,000...

Transaction Expected to Close July 2, 2026 FULLERTON, Calif., June 30, 2026 (GLOBE NEWSWIRE) — Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a biotechnology company developing innovative cancer therapies, today announced that it has amended and restated the previously announced definitive merger agreement with InnocsAI LLC (“InnocsAI”), an oncology biotechnology company focused on next-generation cell therapy technologies. The transaction has been re-structured to allow closing prior to obtaining stockholder approval, with closing now expected to occur on July 2, 2026, subject to the satisfaction or waiver of customary closing conditions. Under the amended terms of the merger agreement, the equity holders of InnocsAI will receive merger consideration consisting of a combination...

The official corporate arm of the Dogecoin Foundation is now a publicly traded company, marking the start of its next phase of growth across payments, treasury, tokenization, and professional sports MIAMI, June 30, 2026 (GLOBE NEWSWIRE) — House of Doge Inc. (“House of Doge” or the “Company”) (NASDAQ: HODO), the official corporate arm of the Dogecoin Foundation, today announced the completion of its previously announced merger with Brag House Holdings, Inc. (formerly NASDAQ: TBH). In connection with the closing, the combined company was renamed House of Doge Inc., and its common stock will begin trading on the Nasdaq under the new ticker symbol “HODO” as of July 1, 2026. Following the closing, the Company has approximately 75.9 million shares outstanding. As a public company, House of Doge gains...

Adaptive ML will join Datadog’s AI lab to build frontier AI infrastructure to address cutting-edge research challenges within observability and security NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Datadog, Inc. (NASDAQ: DDOG), the leading AI-powered observability and security platform, today announced it has acquired Adaptive ML, a frontier AI startup developing the world’s first Reinforcement Learning Operations (RLOps) platform, enabling enterprises to build, own, and deploy their own specialized agents and models. Adaptive ML will join Datadog AI Research, accelerating Datadog’s investment and research efforts around world models and agentic LLM post-training for observability. Datadog AI Research focuses on fundamental technical problems and collaborates with Datadog’s product and engineering teams to translate research...